论文部分内容阅读
目的:分析不同抗菌药物对肿瘤患者抗感染治疗的相关因素。方法:选取医院2014年10月—2016年6月期间收治的各类肿瘤患者112例临床资料,分析其药物使用方式、用药频率及人均药物治疗费用。结果:112例患者无指征用药10例占8.93%,预防性用药20例占17.86%,治疗性用药82例占73.21%;使用头孢菌素类抗菌药物治疗患者所占比例为56.25%(63/112)、林可霉素类药物的比例为14.29%(16/112)以及氨基糖苷类药物居第3位(占12.50%);而头孢菌素类药物的人均治疗费用(658.48±15.46)元为最高。结论:抗菌药物用于肿瘤患者抗感染治疗常采用头孢菌素类抗菌药物,人均药物治疗费用为最高。
Objective: To analyze the related factors of anti-infective treatment of different antimicrobial agents in cancer patients. Methods: The clinical data of 112 patients with various types of cancer admitted during the period from October 2014 to June 2016 in our hospital were selected to analyze their drug usage patterns, frequency of drug use and per capita drug treatment costs. Results: Among 112 patients, 10 cases were without indication medication, accounting for 8.93%, 20.8% were prophylactic medication, 82.2 cases were therapeutic medication, and those with cephalosporin antibiotic therapy were 56.25% (63 / 112), the ratio of lincomycin to drugs was 14.29% (16/112) and aminoglycosides was the third (12.50%), while the cost of cephalosporins was 658.48 ± 15.46 Yuan is the highest. Conclusion: Antibacterial drugs are often used cefalosporine anti-bacterial drugs for the treatment of cancer patients, the highest per capita cost of drug treatment.